Trials / Unknown
UnknownNCT04953221
The Effect of YJ001 on Diabetic Peripheral Neuropathic Pain.
A Randomized, Double-blind, Placebo-controlled, Phase II Clinical Trial to Evaluate the Effectiveness and Safety of Spray YJ001 in the Treatment of Diabetic Peripheral Neuropathic Pain.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 225 (estimated)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
In this study, a randomized, double-blind, placebo parallel-controlled design was used to evaluate the effectiveness and safety of YJ001 spray applied to local skin in patients with diabetic peripheral neuropathic pain, and to explore the best effective dose.
Detailed description
In this study, a randomized, double-blind, placebo parallel-controlled design was used to evaluate the effectiveness and safety of YJ001 spray applied to local skin in patients with diabetic peripheral neuropathic pain, and to explore the best effective dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YJ001 | Skin spray |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2022-07-01
- Completion
- 2023-07-01
- First posted
- 2021-07-07
- Last updated
- 2021-07-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04953221. Inclusion in this directory is not an endorsement.